Libor Žůrek

Person

Born

1979-11-02

via Open Library + Wikidata

Recent publications · Crossref

5 total works indexed

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   · 2015 · cited 6,939x

2. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

   · 2018 · cited 2,968x

3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,779x

4. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,537x

5. First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

   · 2017 · cited 2,069x

via Crossref · CC0

Key dates

Born

2 November 1979

via Wikidata · CC0

Wikidata facts

Instance of

human

Given name

Libor

Gender

male

Citizenship

Czech Republic

Place of birth

Kojetín

Occupation

association football player

Languages spoken

Czech

Sport

association football

Member of team

Czech Republic national under-20 football team

Position played